Evidence map›Paper›PMID 42058524›Full record

ArticleJournal of surgical case reports2026

Epithelioid angiomyolipoma: a rare renal tumor with histopathological complexity.

Mohannad N AbuHaweeleh, Abdelkareem Alhyari, Rajen Goyal, Ibrahim A Khalil, Alaeddin Badawi, Khalid Al-Rumaihi

Abstract readCase Reports
In one paragraph

Article in Journal of surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohannad N AbuHaweelehCollege of Medicine, QU Health, Qatar University, PO Box 2713, Doha, Qatar.ORCID https://orcid.org/0000-0002-6121-5158
Abdelkareem AlhyariDepartment of Laboratory Medicine and Pathology, Hamad Medical Corporation, PO Box 3050, Doha, Qatar.
Rajen GoyalDepartment of Laboratory Medicine and Pathology, Hamad Medical Corporation, PO Box 3050, Doha, Qatar.
Ibrahim A KhalilDepartment of Urology, Ambulatory Care Center, Hamad Medical Corporation, PO Box 3050, Doha, Qatar.
Alaeddin BadawiDepartment of Urology, Ambulatory Care Center, Hamad Medical Corporation, PO Box 3050, Doha, Qatar.
Khalid Al-RumaihiDepartment of Urology, Ambulatory Care Center, Hamad Medical Corporation, PO Box 3050, Doha, Qatar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal angiomyolipomas (AMLs) are rare benign kidney tumors. Epithelioid angiomyolipoma (EAML) is a distinct variant with unique histopathological features and recognized malignant potential. This study highlights the diagnostic features and pitfalls of EAML. A 41-year-old woman was referred after an incidental left renal mass was detected on ultrasound. She was asymptomatic, with unremarkable examination and laboratory results, though her family history included several malignancies. Magnetic resonance imaging revealed a 3.5-cm partly exophytic, posterior lower-pole renal mass without pelvicalyceal invasion. The patient underwent robotic-assisted left partial nephrectomy. Histopathology showed a tumor composed predominantly of epithelioid cells with reduced vascularity, thick-walled vessels, and adipose tissue. Immunohistochemistry demonstrated positivity for smooth muscle actin (SMA) and Human Melanoma Black-45 (HMB-45) and negativity for Paired box 8 (PAX-8), confirming EAML. EAML poses diagnostic and management challenges due to uncertain malignant potential and lack of guidelines. Surgical resection remains primary treatment, with long-term surveillance recommended.

Indexed as

angiomyolipomabenign renal tumorepitheloid angiomyolipomakidney tumoruro-oncology

Identifiers

PMID42058524
PMCPMC13123729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.